These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1029184)

  • 1. [Advantages and limitations of the galactosamine model].
    Decker K
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():245-9. PubMed ID: 1029184
    [No Abstract]   [Full Text] [Related]  

  • 2. Galactosamine induced liver injury.
    Decker K; Keppler D
    Prog Liver Dis; 1972; 4():183-99. PubMed ID: 4631501
    [No Abstract]   [Full Text] [Related]  

  • 3. D-galactosamine and acute liver cell injury.
    Shinozuka H; Farber JL; Konishi Y; Anukarahanonta T
    Fed Proc; 1973 Apr; 32(4):1516-26. PubMed ID: 4701754
    [No Abstract]   [Full Text] [Related]  

  • 4. ["Galactosamine refractory" regenerating liver--a model for studies on the etiology mechanism of galactosamine hepatitis].
    Reutter W; Bauer C; Bachmann W; Lesch R
    Hoppe Seylers Z Physiol Chem; 1972 May; 353(5):747. PubMed ID: 5069316
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of D-penicillamine on the galactosamine hepatitis model in the rat].
    Habersang S; Kozlik V; Leuschner F; von Schlichtegroll A
    Arzneimittelforschung; 1973 Jan; 23(1):56-7. PubMed ID: 4740696
    [No Abstract]   [Full Text] [Related]  

  • 6. The inhibition of rat liver nuclear ribonucleic acid synthesis by galactosamine and its reversal by uridine.
    Konishi Y; Shinozuka H; Farber JL
    Lab Invest; 1974 Jun; 30(6):751-6. PubMed ID: 4835601
    [No Abstract]   [Full Text] [Related]  

  • 7. Protective effect of ammonium ions and L-norvaline on galactosamine induced liver injury.
    Pausch J; Wohleb B; Gerok W
    Hoppe Seylers Z Physiol Chem; 1977 May; 358(5):595-7. PubMed ID: 881166
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatoprotective effect of silymarin (carsil) on liver of D-galactosamine treated rats. Biochemical and morphological investigations.
    Tyutyulkova N; Tuneva S; Gorantcheva U; Tanev G; Zhivkov V; Chelibonova-Lorer H; Bozhkov S
    Methods Find Exp Clin Pharmacol; 1981; 3(2):71-7. PubMed ID: 7230979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Animal experimental studies on the problem of liver damage by antitubercular agents (rifampicin and isoniazide) by means of the galactosamine model].
    Leinweber B; Mahrt R
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():300-3. PubMed ID: 1029192
    [No Abstract]   [Full Text] [Related]  

  • 10. Investigations on d-galactosamine hepatitis after pretreatment with alpha-hexachlorocyclohexane.
    Schuchhardt C; Reutter W; Lesch R
    Beitr Pathol; 1976 Feb; 157(1):45-55. PubMed ID: 57771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of D-galactosamine for a pulse-chase study of ribosomal RNA maturation in rat liver.
    Gajdardjieva KC; Dabeva MD; Chelibonova-Lorer H; Hadjiolov AA
    FEBS Lett; 1977 Dec; 84(1):48-52. PubMed ID: 590526
    [No Abstract]   [Full Text] [Related]  

  • 12. An investigation of the hepatotoxicity of D-galactosamine in different species of animal.
    James GW; Pickering RW; Parker FL
    Arzneimittelforschung; 1975 Oct; 25(10):1593-4. PubMed ID: 1243045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death.
    Decker K; Keppler D
    Rev Physiol Biochem Pharmacol; 1974; (71):77-106. PubMed ID: 4375846
    [No Abstract]   [Full Text] [Related]  

  • 14. [Specific hepatotoxic effect of D-galactosamine].
    Andreicut S; Kerekes M
    Morphol Embryol (Bucur); 1977; 23(3):221-5. PubMed ID: 142915
    [No Abstract]   [Full Text] [Related]  

  • 15. Ultrastructural study of liver cell injury due to UTP deficiency.
    Shinozuka H
    Virchows Arch B Cell Pathol; 1974 Mar; 15(2):119-30. PubMed ID: 4212499
    [No Abstract]   [Full Text] [Related]  

  • 16. [Galactosamine hepatitis: injury to the plasma membrane of hepatic cells following administration of D-galactosamine].
    Reutter W; Bachmann W
    Verh Dtsch Ges Inn Med; 1971; 77():1177-8. PubMed ID: 5155984
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies on the behavior of microsomal enzymes in the rat liver following galactosamine administration].
    Leber HW; Leinweber B; Platt D
    Verh Dtsch Ges Inn Med; 1971; 77():1179-82. PubMed ID: 4346176
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of partial hepatectomy on the hepatotoxicity of D-galactosamine.
    Andreicuţ S; Kerekes M
    Morphol Embryol (Bucur); 1982; 28(2):177-84. PubMed ID: 6213854
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of essential phospholipids on the galactosamine hepatitis in rats].
    Petzold H; Titlbach O
    Cesk Gastroenterol Vyz; 1974 Apr; 28(3):178-80. PubMed ID: 4447983
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhanced D-galactosamine hepatotoxicity after propylthiouracil treatment in the rat.
    Mihas TA; Ceballos R; Hirschowitz BI; Gibson RG; Mihas AA
    J Med; 1982; 13(1-2):71-9. PubMed ID: 6956652
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.